| Tag | Content |
|---|
EnhancerAtlas ID | HS073-10016 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr22:50633470-50634280 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ZNF263 | MA0528.1 | chr22:50633816-50633837 | TCCTCCTGTCCCCACTTCTCC | - | 6.01 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_10100 | chr22:50626727-50634059 | CD14 | | SE_17645 | chr22:50626550-50633991 | CD4p_CD25-_CD45RAp_Naive | | SE_25037 | chr22:50632632-50633698 | Colon_Crypt_3 | | SE_60789 | chr22:50622988-50634005 | DHL6 | | SE_62001 | chr22:50612960-50648669 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I050194 | chr22 | 50633081 | 50633787 |
|
Enhancer Sequence | TGCGCAGCCG CGGGCAAGGG TCAGGGTCAG GGTCGGGGTC AAAGCCACCT GTTTGCCTGT 60
TGCCCAGGTT CCTCTCACAG CCCATGCCCC CAGTCAGTGT GGCTGTGCCT GGCCTGCCCT 120
GGGGATTGCC GGGTTAGGGA CCTCCCCTGG GCCAGGAGAA ATGAAAGAGG CTCCATTACC 180
CGGTTTCAGG CAAGGGAGGA GGAAATGGGT GGCTCTCCAA GCTGAGGCAG GGGCTGGTCA 240
CCCGAGGACT GGGTTGCTGA GCAGTTGCTG GGGATGGGTC AGGTCTCAGT GCAAGGTTGG 300
CCCCCCCGGT ACCACACCCA GGCCCAAAGT GGGTGGGGCT CAGGGCTCCT CCTGTCCCCA 360
CTTCTCCAGC CTTGCAGTGA CCGGAGAGGC AGGACTTTCT CATTGCTCTT TGTGTTTTCG 420
GTTTTTGTTT TTTTTTTTTG AGACAGAGTC TCGCTCTGTT GCCCAGGCTG GAGTGCAGTG 480
GTGCGATCTT GGCTCACTGC AACCTTCGCC TCCTGGGTTC TAGTGATGCT CCCGCCTCAG 540
CCTCCTGAGT AGCTGGGATT ACAGGTGCCT GCCACCACAC CTGGCTAATT TTTTGTATTT 600
TTAGTAGAGA CGGGGTTTCA CCATGTTGCC CAGGTTCATC TCAAACTCCT GAGCTCAGGC 660
AATCCACCCA CCTCAGCCTC CCAAAGTGCT GGGAATACAG GCATGAGCCA CCGCGCCCGG 720
CCAGGCTTTG TGTTTTCAAA GGGGGCCCAG CACGCCTGAC CCCAGCCCTG GTCAGTTTGC 780
CTTCCCCCTG TTCAAAGGAA ACAATTATAA 810
|
